Top Health Tech Companies in Pittsburgh, PA (107)
Matter is a Brand Elevation Agency that integrates PR, marketing and creative services into content-rich campaigns that inspire action and build value. Founded in 2003, with eight offices spanning North America, Matter works with the world’s most innovative companies across healthcare, high-technology, consumer technology and consumer markets.
Jacobian empowers physicians to deliver diagnostic excellence for every patient. Radiologists and pathologists are overburdened, and the industry can’t keep up with imaging demand. Jacobian exists to solve that problem. "Intelligence Amplified" reflects Jacobian’s core philosophy: Enhancing - not replacing - human expertise with AI and automation.
LifeStance Health is a behavioral health care company focused on providing evidenced-based, medically driven treatment services for children, adolescents and adults suffering from a variety of mental health issues in care settings that include acute inpatient, partial hospitalization, intensive outpatient, outpatient, community-based and in-home. Our Vision: A truly healthy society where mental and physical healthcare are unified to make lives better....
Here at Aetna, a CVS Health business, we are building a healthier world by making healthcare easy, affordable and all about you. Follow our LinkedIn page for company news, industry commentary, jobs and more. Founded in 1853 in Hartford, CT, Aetna is one of the nation's leading diversified health care benefits companies, serving an estimated 46.7 million people with information...
Pinnacle Treatment Centers is a leading provider of comprehensive substance use disorder treatment services. Founded in 2006, Pinnacle has expanded into nine states (California, Georgia, Indiana, Kentucky, New Jersey, North Carolina, Ohio, Pennsylvania, and Virginia) and includes Aegis, Recovery Works, Stepping Stone, and more in our Pinnacle Family of Companies. Pinnacle was created to help individuals, families, and communities combat...
ZOLL Medical Corporation, an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire...
ZOLL Medical Corporation's Top Stability & Growth Strengths
Strong Revenue Growth: Consistent disclosures describe revenue scaling from earlier sub‑billion levels to a multi‑billion business, with segment updates indicating continued expansion. Parent commentary cites rising sales and operating income supported by new launches and portfolio additions.
Innovation-Driven Growth: A steady cadence of FDA approvals and U.S. launches (e.g., next‑generation LifeVest and Zenix) alongside acquisitions such as select Vyaire ventilator lines signals a pipeline that supports growth. Feedback suggests refreshed offerings in core categories are intended to drive adoption across EMS, hospital, and outpatient settings.
Strong Market Position & Advantage: ZOLL is portrayed as the clear leader in wearable defibrillators and a top‑tier competitor in external defibrillation, operating globally with strong backing from its parent. Evidence of federal procurement wins and an expanded installed base through acquisitions indicates durable competitive standing.
Medspas are booming, and are often a path for individual nurses to become business owners. We believe that’s a good thing for them, their communities, local economies, and clients. We unlock the entrepreneurial opportunity in aesthetics for those with the moxie to take the leap. Moxie gives aesthetic entrepreneurs everything they need to successfully compete (and win) against even the biggest...
At Cigna, we're more than a health insurance company. We are your partner in total health and wellness. And we’re here for you 24/7 – caring for your body and mind. As a global health service company, Cigna's mission is to improve the health, well-being, and peace of mind of those we serve by making health care simple, affordable, and predictable. Our...
Cigna's Top Stability & Growth Strengths
Profitability: Cigna is described as reporting strong profitability through 2025, with multi‑billion profits and guidance pointing to higher EPS. Evernorth is positioned as the primary earnings engine supporting that profitability.
Strong Revenue Growth: Total revenues are described as rising strongly through 2024 and 2025, with continued growth implied by 2026 adjusted revenue guidance. Growth is characterized as being driven primarily by Evernorth’s PBM, specialty pharmacy, and care services businesses.
Future-Ready Strategy: The company is portrayed as intentionally shifting to a services‑led model after the Medicare divestiture, emphasizing specialty pharmacy, behavioral health, and a move toward a rebate‑free PBM approach. This repositioning is framed as an adaptation to evolving market expectations around transparency and affordability.
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
Viatris's Top Stability & Growth Strengths
Cost & Operational Efficiency: Cost-savings efforts are positioned as a concrete lever to support improved earnings and fund growth priorities, with an enterprise-wide program targeting substantial savings over multiple years. Guidance frames these actions as part of a broader move toward sustained revenue and earnings improvement beginning in 2026.
Resilient & Sustainable Growth: Growth is presented as re-emerging, with management guiding to a return to modest year-over-year revenue expansion in 2026 after a softer 2025. Improving quarterly trends exiting 2025 and a baseline of modest operational growth excluding divestitures support a narrative of stabilization.
Strong Market Position & Advantage: Scale and global reach are repeatedly highlighted as a stabilizing advantage, with broad geographic coverage and a large portfolio supporting access, supply reach, and competitive standing in off-patent medicines. The strategic shift toward complex generics and specialty brands is framed as reinforcing the company’s long-term positioning against pricing pressures.
A mental health practice for kids and young adults struggling with social, developmental, and school-related challenges. We are dedicated to achieving better outcomes, faster, by taking the trial and error out of diagnosis and treatment
AlixaRx provides advanced pharmacy services to post‐acute healthcare facilities through a new model that leverages technology to deliver medication therapy management. AlixaRx is a differentiated approach because it utilizes a combination of clinical pharmacists, automated dispensing units, and electronic medication cabinets to meet the medical needs of patients and residents at each facility. AlixaRx delivers improved safety, creates better access...
Founded in 1986, Cranial Technologies is the only company in the world solely dedicated to treating infants with plagiocephaly. It’s our mission to provide the best possible treatment, experience and outcome for every family who seeks our care. To date, we’ve cared for approximately 175,000 babies using our proven safe and effective DOC Band® cranial orthotic. In 1998, Dynamic Orthotic Cranioplasty®,...
RAND Europe is an independent, not-for-profit research organization whose mission is to help improve policy and decision-making through research and analysis. It conducts objective, evidence-based research across a wide range of public policy areas, including health, national security, education, and social issues. By providing rigorous analysis and innovative methodologies, RAND Europe aims to create effective, enduring solutions that benefit the...
Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI,...
Abridge AI's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Capital access is described as exceptional, with over $1B in total funding and a valuation rising to $5.3B across successive rounds backed by top‑tier and strategic investors. This depth of financing signals ample runway for R&D and go‑to‑market scale.
Strong Revenue Growth: Revenue momentum is highlighted by contracted ARR of $117M in early 2025 and estimates that actual ARR crossed $100M by mid‑2025, alongside a 4x increase over 18 months. These points indicate rapid monetization of enterprise deployments.
Market Expansion: Enterprise adoption expanded from roughly 100–150 health systems in early/mid‑2025 to more than 250–300 by mid‑2026, including large rollouts at Kaiser Permanente and other marquee systems. Scaling conversation volume from ~50M in 2025 to a projected 80M+ in 2026 underscores a widening footprint.
At Krystal Biotech, Inc., our mission is to make a meaningful difference in the lives of underserved patient populations suffering from debilitating skin diseases. We work to accomplish this goal through scientific innovation and operational excellence, believing that "nature operates in the shortest way possible" (Aristotle). We are a clinical-stage gene therapy company using our proprietary, engineered virus vector platform to...
ATI Advisory is a healthcare research and advisory services firm dedicated to system reform that improves health outcomes and makes care easier for everyone. ATI guides public and private leaders in developing scalable solutions. Its nationally recognized experts apply the highest standards in research and advisory services along with deep expertise to generate new ideas, solve hard problems, and reduce...
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love...
Smith & Nephew's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show mid-single-digit underlying growth through 2024–2025, with management reiterating guidance for continued growth in 2026. Early 2026 updates indicate broad-based contributions across units despite some subsegment variability.
Profitability: Trading profit and margins improved, supported by execution of the 12‑Point Plan and the transition to the RISE strategy. Management is guiding to further profit growth alongside higher returns.
Healthy Cash Flow: Free cash flow strengthened in 2025 with guidance for robust generation in 2026. Share repurchases completed and newly announced buybacks signal confidence and disciplined capital allocation.
Treatspace is a platform where they can post accurate, up-to-date, and verifiable facts about their practices.
Our solutions support providers in specialty medical settings across the continuum of healthcare—from hospital to home. Our interoperable EMRs deliver end-to-end solutions that ensure compliance, improve outcomes, empower providers and inspire care. We serve over 14,000 facilities, including 98% of the largest hospital chains, two thirds of skilled nursing facilities and many leading hospice organizations and private practices. Net Health...
